Biocept Inc
BIOC·Stocks·Medical Or Nursing Services·United States·OTC Markets Stock Exchange·USD
Price
$4.42
Today
+0.0%
YTD
+0.0%
About
Biocept is an early stage molecular oncology diagnostics company that was founded in 1997 and operates within the US. With headquarters in San Diego, California, the company is involved in the development and commercialisation of proprietary circulating tumour cell and DNA assays. Biocept is listed on the NASDAQ CM stock market under the ticker BIOC. Keep an eye on the BIOC share price by adding this stock to your eToro watchlist.
Price chart
Closing price history for BIOC (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)0.00
P/S (TTM)0.00
P/B (TTM)0.00
Market cap$300.00
Cap tierMicro-cap
Industry avg P/E25.72
Profitability
Gross margin22.84%
EBIT margin-47.85%
Net margin-616.47%
ROE-77.58%
ROA-42.76%
Earnings & Revenue
Revenue (TTM)$45.54M
Revenue growth (1Y)-30.8%
EPS (TTM)-$39.28
Free cash flow$-8.75M
Total debt$11.59M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)9909.44
Employees52
Next earnings13 Nov '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.